Identification of a 55-kDa ezrin-related protein that induces cytoskeletal changes and localizes to the nucleolus

Experimental Cell Research

Volumn 250, Issue 1, 1999, Pages 51-61

  Kaul, Sunil C ^a   Kawai, Rena ^a   Nomura, Hitoshi ^b   Mitsui, Youji ^a   Reddel, Roger R ^c   Wadhwa, Renu ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Cell morphology; Ezrin; Nucleolar localization

Indexed keywords

EZRIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRUCTURE; CYTOSKELETON; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; STAINING;

EID: 0033542725     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4491     Document Type: Article

References (45)

1. Gould K. L., Bretscher A., Esch F. S., Hunter T. cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J. 8:1989;4133-4142.
2. Arpin M., Algrain M., Louvard D. Membrane-actin microfilament connections: An increasing diversity of players related to band 4.1. Curr. Opin. Cell Biol. 6:1994;136-141.
3. Tsukita Sa., Yonemura S., Tsukita Sh. ERM proteins: Head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem. Sci. 22:1997;53-58.
4. Tsukita Sa., Yonemura S., Tsukita Sh. ERM (ezrin/radixin/moesin) family: From cytoskeleton to signal transduction. Curr. Opin. Cell Biol. 9:1997;70-75.
5. Vaheri A., Carpen O., Heiska L., Helander T. S., Jaaskelainen J., Majander-Nordenswan P., Sainio M., Timonen T., Turunen O. The ezrin protein family: Membrane-cytoskeleton interactions and disease associations. Curr. Opin. Cell Biol. 9:1997;659-666.
6. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 72:1993;791-800.
7. Funayama N., Nagafuchi A., Sato N., Tsukita Sa., Tsukita Sh. Radixin is a novel member of the band 4.1 family. J. Cell Biol. 115:1991;1039-1048.
8. Sato N., Funayama N., Nagafuchi A., Yonemura S., Tsukita Sa., Tsukita Sh. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J. Cell Sci. 103:1992;131-143.
9. Lamb R. F., Ozanne B. W., Roy C., McGarry L., Stipp C., Mangeat P., ïay D. G. Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts. Curr. Biol. 7:1997;682-688.
10. r 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization. J. Biol. Chem. 264:1989;16727-16732.
11. Tsukita Sa., Oishi K., Sato N., Sagara J., Kawai A., Tsukita Sh. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:1994;391-401.
12. Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita Sa., Tsukita Sh. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell Biol. 140:1998;885-895.
13. Kotani H., Takaishi K., Sasaki T., Takai Y. Rho regulates association of both the ERM family and vinculin with the plasma membrane in MDCK cells. Oncogene. 14:1997;1705-1713.
14. Hirano M., Sato N., Kondo T., Yonemura S., Monden M., Sasaki T., Takai Y., Tsukita Sh., Tsukita Sa. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135:1996;37-51.
15. Bretscher A., Gary R., Berryman M. Soluble ezrin purified from placenta exists as stable monomers and elongated dimers with masked C-terminal ezrin-radixin-moesin association domains. Biochemistry. 34:1995;16830-16837.
16. Chen J., Cohn J. A., Mandel L. J. Dephosphorylation of ezrin as an early event in renal microvillar breakdown and anoxic injury. Proc. Natl. Acad. Sci. USA. 92:1995;7495-7499.
17. Gary R., Bretscher A. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol. Biol. Cell. 6:1995;1061-1075.
18. Martin M., Andreoli C., Sahuquet A., Montocourrier P., Algrain M., Mangeat P. Ezrin NH2-terminal domain inhibits the cell extension activity of the COOH-terminal domain. J. Cell Biol. 128:1995;1081-1093.
19. Scherer S. S., Gutmann D. H. Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J. Neurosci. Res. 46:1996;595-605.
20. Gutmann D. H. Molecular insights into neurofibromatosis 2. Neurobiol. Dis. 3:1997;247-261.
21. Lloyd A., Yancheva N., Wasylyk B. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature. 352:1991;635-638.
22. Takeuchi K., Sato N., Kasahara H., Funayama N., Nagafuchi A., Yonemura S., Tsukita S., Tsukita S. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J. Cell Biol. 125:1994;1371-1384.
23. Kaul S. C., Mitsui Y., Komatsu Y., Reddel R. R., Wadhwa R. A highly expressed 81 kDa protein in immortalized mouse fibroblast: Its proliferative function and identity with ezrin. Oncogene. 14:1996;1231-1237.
24. Kaul S. C., Wadhwa R., Sugihara T., Obuchi K., Komatsu Y., Mitsui Y. Identification of genetic events involved in early steps of immortalization of mouse fibroblasts. Biochim. Biophys. Acta. 1201:1994;389-396.
25. Wadhwa R., Pereira-Smith O. M., Reddel R. R., Sugimoto Y., Mitsui Y., Kaul S. C. Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp. Cell Res. 216:1995;101-106.
26. Resh M. D., Erikson R. L. Highly specific antibody to Rous sarcoma virus src gene product recognizes a novel population of pp60v-src and pp60c-src molecules. J. Cell Biol. 100:1985;409-417.
27. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
28. Wadhwa R., Kaul S. C., Ikawa Y., Sugimoto Y. Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J. Biol. Chem. 268:1993;6615-6621.
29. Hanzel D., Reggio H., Bretscher A., Forte J. G., Mangeat P. The secretion-stimulated 80K phosphoprotein of parietal cells is ezrin, and has properties of a membrane cytoskeletal linker in the induced apical microvilli. EMBO J. 10:1991;2363-2373.
30. Yao X., Thibodeau A., Forte J. G. Ezrin-calpain I interactions in gastric parietal cells. Am. J. Physiol. 265:1993;C36-C46.
31. Dingwall C., Laskey R. A. Nuclear targeting sequences - A consensus. Trends Biochem. Sci. 16:1991;478-481.
32. Mirski S. E., Gerlach J. H., Cummings H. J., Zirngibl R., Greer P. A., Cole S. P. Bipartite nuclear localization signals in the C terminus of human topoisomerase II alpha. Exp. Cell Res. 237:1997;452-455.
33. Jooss K. U., Muller R. Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation. Oncogene. 10:1995;603-608.
34. Xu L., Gonzalez-Agosti C., Beauchamp R., Pinney D., Sterner C., Ramesh V. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells. Exp. Cell Res. 238:1998;231-240.
35. Hitotsumatsu T., Iwaki T., Kitamoto T., Mizoguchi M., Suzuki S. O., Hamada Y., Fukui M., Tateishi J. Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study. Acta Neuropathol. 93:1997;225-232.
36. Gutmann D. H., Sherman L., Seftor L., Haipek C., Lu K. H., Hendrix M. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. Hum. Mol. Genet. 8:1999;267-275.
37. Ono Y., Sorimachi H., Suzuki K. Structure and physiology of calpain, an enigmatic protease. Biochem. Biophys. Res. Commun. 245:1998;289-294.
38. Carafoli E., Molinari M. Calpain: A protease in search of a function. Biochem. Biophys. Res. Commun. 247:1998;193-203.
39. Algrain M. O., Turunen A., Vaheri D. L., Arpin M. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J. Cell Biol. 120:1993;129-139.
40. Potter D. A., Tirnauer J. S., Janssen R., Croall D. E., Hughes C. N., Fiacco K. A., Mier J. W., Maki M., Herman I. M. Calpain regulates actin remodeling during cell spreading. J. Cell Biol. 141:1998;647-662.
41. Villa G. P., Henzel W. J., Sensenbrenner M., Henderson. C. E., Pettmann B. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J. Cell Sci. 111:1998;713-722.
42. Roy C., Martin M., Mangeat P. A dual involvement of the amino-terminal domain of ezrin in F- and G-actin binding. J. Biol. Chem. 272:1997;20088-20095.
43. Bolton S. J., Barry S. T., Mosley H., Patel B., Jockusch B. M., Wilkinson J. M., Critchley D. R. Monoclonal antibodies recognizing the N- and C-terminal regions of talin disrupt actin stress fibers when microinjected into human fibroblasts. Cell Motil. Cytoskel. 36:1997;363-376.
44. Martin M., Roy C., Montcourrier P., Sahuquet A., Mangeat P. Three determinants in ezrin are responsible for cell extension activity. Mol. Biol. Cell. 8:1997;1543-1557.
45. Crepaldi T., Gautreau A., Comoglio P. M., Louvard D., Arpin M. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138:1997;423-434.